Murugan Amar 4
4 · Atara Biotherapeutics, Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
Murugan Amar
SVP, GC & Secretary
Transactions
- Sale
Common Stock
2023-08-16$1.65/sh−3,622$5,987→ 265,391 total - Sale
Common Stock
2023-08-16$1.65/sh−5,050$8,343→ 269,013 total
Footnotes (3)
- [F1]Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2023 and August 17, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
- [F3]Includes 3,118 shares purchased under the Issuer's Employee Stock Purchase Plan on May 31, 2023.